Search
  1. Home
  2. Southern Africa
  3. South Africa

Company granted license to make generic anti-AIDS medicine

    JOHANNESBURG

    US drugmaker Bristol-Myers Squibb has licensed a South African laboratory to make cheaper generic copies of two of its anti-AIDS medications for sale in sub-Saharan Africa, SAPA reported on Friday.

    Robert Laverty, spokesperson for Bristol-Myers Squibb, was quoted as saying “we’re honouring the pledge made in March”. The licence to Aspen Pharmacare covers Bristol-Myers’ Videx and Zerit drugs and is valid for five years, although it can be extended, Laverty said. Bristol-Myers will not receive royalties from the deal.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join